Exercise during curative chemotherapy for breast cancer has proven benefits. It helps reduce fatigue, preserve muscle strength, improve fitness, and enhance overall quality of life. Staying physically active…
With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
NEW YORK (Reuters Health) – In postmenopausal women with osteopenia, zoledronic acid, given either once-yearly or as a single infusion, is well tolerated and effective in preventing bone…
NEW YORK (Reuters Health) – Iatrogenic preterm delivery is common among women diagnosed with invasive cancer during pregnancy, a new multicenter study shows. The study, published online in…
NEW YORK (Reuters Health) – Tamoxifen therapy has been linked to an increased risk of deep venous thrombosis (DVT) and pulmonary embolism (PE) and now new research suggests…
NEW YORK (Reuters Health) – In a phase III trial in women with HER2/hormone receptor-copositive metastatic breast cancer, the combination of trastuzumab plus anastrozole improved outcomes compared to…
NEW YORK (Reuters Health) – In utero exposure to selective serotonin reuptake inhibitors (SSRIs) may increase the risk of early delivery, low Apgar score at 5 minutes, and…
NEW YORK (Reuters Health) – Treatment of mild gestational diabetes mellitus (GDM) cut the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders in a study…
NEW YORK (Reuters Health) – In young women, the presence of lupus anticoagulant is associated with a more than 40-fold increased risk of stroke and 5-fold increased risk…
NEW YORK (Reuters Health) – The results of a large population-based study in Denmark suggest that children born to women who use selective serotonin reuptake inhibitors (SSRIs) in…
NEW YORK (Reuters Health) – Women who become mothers are more likely to develop the metabolic syndrome during middle age than are their nulliparous counterparts, prospective study findings…
NEW YORK (Reuters Health) – Diabetes is an independent risk factor for atrial fibrillation in women, U.S. investigators report in the October issue of Diabetes Care. The disease…
